Quarterly report pursuant to Section 13 or 15(d)

SUBSEQUENT EVENTS

v3.22.2
SUBSEQUENT EVENTS
6 Months Ended
Jun. 30, 2022
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS SUBSEQUENT EVENTS
On July 13, 2022, following the approval of the 2022 Plan, the Company filed its Registration Statement on Form S-8, pursuant to which the Company issued RSU’s to the Board of Directors totaling 238,970 units.

On August 2, 2022, the Company entered into a supplemental agreement to the partnership agreement dated January 31, 2022 with LIVMOR.
The supplemental agreement states the Company will pay an additional $200,000 for the source code access under the partnership agreement. Payments totaling $200,000 have been made by the Company and LIVMOR has delivered to the Company copies of source materials and codes. All licenses granted by LIVMOR will automatically be converted into a non-exclusive and perpetual license and become licenses granted on a royalty-free and fully paid-up basis, in which LIVMOR hereby expressly waives and relinquishes all HeartBeam payment obligations under the initial partnership agreement.